4.1 Article

Magnetic Resonance Spectroscopy in Metabolic Disorders

Journal

NEUROIMAGING CLINICS OF NORTH AMERICA
Volume 23, Issue 3, Pages 425-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.nic.2012.12.013

Keywords

Hypomyelination; Leukodystrophy; Leukoencephalopathy; Metabolic diseases; MR spectroscopy; White matter

Ask authors/readers for more resources

Magnetic resonance spectroscopy (MRS) is a powerful clinical tool for investigating the metabolic characteristics of neurologic diseases. Proton (H-1)-MRS is the most commonly used and widely available method. In this article, a brief introduction regarding technical issues of H-1-MRS applied to the study of metabolic diseases is followed by a description of findings in some of the most common entities in this large, heterogeneous group of neurologic disorders. The aim was to provide a focused representation of the most common applications of H-1-MRS to metabolic disorders in a routine clinical setting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available